Company Intec Pharma Ltd TEL AVIV STOCK EXCHANGE

Equities

NTEC

IL0011177958

Delayed TEL AVIV STOCK EXCHANGE Other stock markets			5-day change	1st Jan Change
- ^ILa	-.--%		-0.67%	-16.62%

Mar. 14	Top Premarket Gainers	MT
Mar. 13	Indaptus Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Business Summary

Intec Pharma Ltd is an Israel-based drug development company. It is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel gastro-retentive delivery system, improves the pharmacokinetics and pharmacodynamics of various drugs. The Company is focusing on the clinical development program for the Phase III clinical study of the Accordion Pill Carbidopa Levodopa (AP-CDLD), for the treatment of advanced stages Parkinson's disease patients. Its pipeline also comprises The Accordion Pill-Zaleplon, a drug for sleep onset, which is in Phase II clinical program. Furthermore under research is Accordion Pill-Undisclosed Drug for the prevention and treatment of small bowel non-steroidal anti-inflammatory drug (NSAID) induced ulcers.

Managers

Managers	Title	Age	Since
Michael Newman FOU	Founder	68	21-02-23
Jeffrey Meckler CEO	Chief Executive Officer	57	21-08-02
Nir Sassi DFI	Director of Finance/CFO	48	21-06-30
Roger Waltzman CTO	Chief Tech/Sci/R&D Officer	56	23-08-06
Walt Linscott COO	Chief Operating Officer	63	21-06-30

Members of the board

Members of the board	Title	Age	Since
William Hayes BRD	Director/Board Member	58	21-08-02
Jeffrey Meckler CEO	Chief Executive Officer	57	21-08-02
Robert E. Martell BRD	Director/Board Member	61	23-01-12
Hila Karah BRD	Director/Board Member	55	21-06-30
Michael Newman FOU	Founder	68	21-02-23
Roger Pomerantz CHM	Chairman	67	21-07-31
Anthony Maddaluna BRD	Director/Board Member	71	21-06-30
Mark Gilbert BRD	Director/Board Member	63	21-10-31

Shareholders

Name	Equities	%	Valuation
Michael Newman 16.02 %	1,368,356	16.02 %	3 M ILa
Glen Anderson 13.94 %	1,190,400	13.94 %	3 M ILa
Vanguard Group, Inc. (Subfiler) 3.001 %	256,265	3.001 %	574 034 ILa
The Investment House LLC 1.200 %	102,437	1.200 %	229 459 ILa
Jeffrey Meckler 0.8827 %	75,374	0.8827 %	168 838 ILa
Geode Capital Management LLC 0.6414 %	54,767	0.6414 %	122 678 ILa
Strategy Asset Managers LLC 0.5309 %	45,336	0.5309 %	101 553 ILa
Pine Valley Investments LLC 0.5181 %	44,240	0.5181 %	99 098 ILa
Renaissance Technologies LLC 0.3443 %	29,400	0.3443 %	65 856 ILa
Vivaldi Capital Management LP 0.2811 %	24,000	0.2811 %	53 760 ILa

Company contact information

Indaptus Therapeutics, Inc.

3 Columbus Circle 15th floor

10019, New York

http://indaptusrx.com

Sector

This company's sector is not yet available